Skip to content

SAARBACH DINO

Active Risk: not assessed
Private limited companyfounded 2018active for 8 yearsRue des Frênes 1, 4052 Chaudfontaine, BelgiumKBO/BCE: BE 0692.983.638

From the official registers: KBO 8 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

SAARBACH DINO has a registered holding activity and consists mainly of financial fixed assets. The bankruptcy model is trained on trading and manufacturing companies and does not apply here. The 2025 annual accounts show equity of €1.1m and a net result of €43,637. Equity has been growing by about 51% per year since 2018. Its solvency ranks better than 88% of 5,036 sector peers (NACE 47, financial year 2025). The company has been active since 2018 and the Belgian Official Gazette contains no insolvency or warning signals.

Overview

Official details

KBO
Status
Active since 27-03-2018 Normal situation
Activity
Retail sale of pharmaceutical products NACE 47730and 1 other
Establishment unit
2.274.250.914 4052 Chaudfontaine, since 01-04-2018
Financial year end
31 December
Peppol
Reachable since 07-07-2025

Financial position

Holding: outside the score modelBankruptcy probability: sector outside the model
Annual accounts 2025
Gross margin
€74,530
▼ 35.7%
Turnover
≈ €360,000
estimated
Profit
€43,637
▼ 95.5%
Equity
€1.1m
▲ 4.0%
Total assets
€1.4m
▲ 15.3%
Net result -96%: other schema
Filed on 03-06-2026, 58 days before the deadlinePDF
SignalsneutralLatest accounts filed on timeShow the evidence

Checked score

Outside the general model
Holding: general score not applicable
The company has a registered holding activity. Financial fixed assets make up more than half of its assets. The general model for operating companies does not fit such a balance sheet, so there is no score and no financial strength.
Bankruptcy probability within 12 months

The company is a financial institution: a bank, insurer or financial holding. Its balance sheet works differently from that of a trading or manufacturing company. A bankruptcy probability from the general model would mislead here.

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

1 signal.
neutral
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 03-06-2026, 58 days ahead of the deadline.
NBB · 8 filings
Deviation from the deadline
2025
58 days early
2024
65 days early
2023
64 days early
2022
61 days early
2021
60 days early
2020
54 days early
2019
64 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 61 days before the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 May (5 of the last 5 accounts filed within 30 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
01-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Result fell in 2025different schema filed ▼ 95.5% View
  • Positive: Higher solvency than 87% of companies in retail tradesector median 36.1% · 5,036 companies 78.0% View
  • Positive: Always filed on timeaccounts within the deadline every year 8 years View
  • Positive: 8 profitable years in a rowprofit 2025: €43,637 8 years View

Comparable companies

These companies have the same main activity as SAARBACH DINO: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €1.1m and €1.9m, founded between 2013 and 2019.

CompanyTotal assetsGross margin
SAARBACH DINO Chaudfontaine€1.4m€0.07m
VERBIFARMA Pittem€1.5m€0.09m
ASAPHARM Gembloux€1.9m€0.1m
DEGROFARM Deinze€1.5m€0.1m
Pharmacie de Lincent Lincent€1.3m€0.1m
PHARMA 310505 Brugge€1.1m€0.1m
DIEUSAERT PHARMA Heuvelland€1.4m€0.1m
Full comparison

Documents

Annual accounts at the NBB

All 8 annual accounts

Articles and registers

Key facts about SAARBACH DINO

What is the company number of SAARBACH DINO?
The company number of SAARBACH DINO is 0692.983.638. The VAT number is the same number with BE in front: BE 0692.983.638.
Where is SAARBACH DINO based?
The registered office is at Rue des Frênes 1, 4052 Chaudfontaine.Company details
What does SAARBACH DINO do?
According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of SAARBACH DINO?
The legal form of SAARBACH DINO is Private limited company (BV).
When was SAARBACH DINO founded?
SAARBACH DINO was founded on 27-03-2018.
Is SAARBACH DINO still active?
Yes, SAARBACH DINO is an active enterprise in the KBO register.
What is the turnover of SAARBACH DINO?
The turnover in financial year 2025 is ≈ €360,000. This figure is estimated from the gross margin of €74,530 and 73 comparable companies (NACE 477). It probably lies between €180,000 and €520,000.Financials
Is SAARBACH DINO profitable?
In financial year 2025, SAARBACH DINO made a profit of €43,637.
Where can I find the annual accounts of SAARBACH DINO?
SAARBACH DINO filed 8 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts 2025 (PDF)
When are the next annual accounts of SAARBACH DINO due?
SAARBACH DINO must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.